Application of Artificial Intelligence and Machine Learning in Drug Discovery

Area of Science:

• Pharmaceutical research and development
• Artificial Intelligence in drug discovery

Background:

• Machine Learning (ML) and Deep Learning (DL) are subclasses of Artificial Intelligence (AI).
• The increasing volume of big data presents opportunities for AI in pharmaceutical R&D.
• AI methods have seen recent advancements and successful applications in drug discovery.

Purpose of the Study:

• To provide an overview of ML and DL methods in pharmaceutical R&D.
• To illustrate the application of these methods across various drug discovery workstreams.
• To highlight potential pitfalls and limitations when using AI in drug discovery.

Main Methods:

• Overview of Machine Learning (ML) and Deep Learning (DL) techniques.
• Application of AI across generative chemistry, ADMET prediction, and retrosynthetic analysis.
• Discussion of challenges and limitations in AI implementation.

Main Results:

• AI, ML, and DL are effectively translating data into knowledge for drug discovery.
• These technologies are being applied to diverse areas such as generative chemistry and ADMET prediction.
• The study identifies areas for cautious application and potential pitfalls.

Conclusions:

• AI, ML, and DL offer powerful tools for accelerating pharmaceutical discovery and development.
• Successful application across multiple workstreams demonstrates the value of these technologies.
• A critical approach is necessary to mitigate risks and overcome limitations in AI adoption.